Skip to main content
. 2022 Oct 24;8(4):00240-2022. doi: 10.1183/23120541.00240-2022

FIGURE 1.

FIGURE 1

Phase I study in healthy males: subject flow. #: one patient prematurely discontinued the study after taking 48 mg BI 1015550 due to an adverse event that was not considered drug-related (ligament sprain). SRD: single rising dose; MRD: multiple rising dose.